REMEGENIX

RemeGenix is developing its lead drug candidate MoBA as a disease modifying treatment for Alzheimer's disease (AD)... RemeGenix is dedicated to the development of disease modifying drugs that can be used to treat Alzheimer's and technology platforms that can further the understanding of this complex disease.

Also known as: RemeGenix, Inc.

Primary location: Bethesda United States